How AI can help personalise and predict health care
Produced by Niharika Nanda
Edited and mixed by Suresh Pawar
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
8 hours ago
- Business Standard
Apollo, Siemens collaborate to advance liver healthcare with AI innovation
Apollo Hospitals and Siemens Healthineers on Wednesday announced a research collaboration founded on a shared ambition to advance innovations in artificial intelligence (AI) and imaging technologies, with the goal of improving lives. The research, spanning quantitative ultrasound imaging to AI-driven clinical solutions, aims to enhance liver disease management by improving patient care pathways and outcomes—from early detection and risk stratification to monitoring intervention and therapy response. The partnership combines technical and clinical expertise to develop innovative healthcare solutions for the growing burden of liver diseases in India, with a focus on early diagnosis, accurate detection, and precise monitoring to improve patient outcomes. As per Government of India guidelines, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), referred to as NAFLD in the report, is a growing cause of liver disease in India. Its prevalence ranges from 9 per cent to 32 per cent and is higher among individuals who are overweight, obese, or have diabetes. According to NFHS-4 (2015–2016), 18–20 per cent of adults are overweight or obese and 3–8 per cent have abnormal blood sugar levels. MASLD significantly increases cardiovascular risk, with heart disease being the leading cause of death. 'At Apollo, we believe that the future of healthcare lies at the intersection of clinical excellence and cutting-edge technology anchored in patient centricity. Our collaboration with Siemens Healthineers is a transformative step in using AI to redefine non-invasive diagnostics for liver disease. Due to diagnostic challenges and the evolving understanding of the disease, the true prevalence of MASLD may be underestimated. This poses a significant public health challenge, requiring increased awareness, early detection, and effective management strategies,' said Sangita Reddy, joint managing director, Apollo Hospitals. 'AI-driven disease progression models will play a pivotal role in the early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes. These models will also facilitate precision population health strategies and clinical decision support across care settings. This partnership reflects Apollo's pioneering vision to embed intelligent systems across the clinical spectrum that enable faster, more accurate diagnoses and proactive patient management,' she added. 'Liver disease is a growing health concern in India. It's crucial to prioritise early diagnosis and prevention through advanced diagnostic tools, lifestyle changes, and increased awareness to reverse this trend. We believe that advanced technologies will aid timely and precise diagnosis, leading to better disease management and improved quality of life for patients. Our joint effort will help address the unmet needs in liver disease diagnosis and treatment, and we look forward to a fruitful partnership,' said Hariharan Subramanian, managing director, Siemens Healthcare. Following the 2024 memorandum of understanding, the Master Research Agreement (MRA) was formalised in March 2025, establishing a foundation for collaborative research in diagnostic and interventional ultrasound imaging. The signing ceremony for the MRA addendum was held on July 23, 2025, in Hyderabad, marking a significant milestone in this partnership.
News18
8 hours ago
- News18
Apollo, Siemens collaborate to advance innovation in liver healthcare
New Delhi, Jul 23 (PTI) Apollo Hospitals and Siemens Healthineers have joined hands for a research collaboration to advance innovation in liver healthcare. The research, spanning quantitative ultrasound imaging to AI-driven clinical solutions, aims to enhance liver disease management by improving patient care pathways and outcomes — from early detection and risk stratification to monitoring intervention and therapy response, the companies said in a statement. 'Our collaboration with Siemens Healthineers is a transformative step in using AI to redefine non-invasive diagnostics for liver disease," Apollo Hospitals Joint Managing Director Sangita Reddy said. AI-driven disease progression models shall play a pivotal role in early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes, she added. 'We believe that advanced technologies will aid timely and precise diagnosis, leading to better disease management and improving the quality of life for patients. Our joint effort will help address the unmet needs in liver disease diagnosis and treatment, and we look forward to a fruitful partnership," Hariharan Subramanian, Managing Director at Siemens Healthcare, said. PTI MSS MSS SHW Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Fashion Value Chain
09-07-2025
- Fashion Value Chain
Siemens Healthineers Boosts Manipal Hospice (MHRC) Therapy Block with Major CSR Support
Manipal Academy of Higher Education (MAHE) proudly acknowledges the generous contribution of Rs. 1 crore from Siemens Healthineers India which funded state-of-the-art Therapy Block at the Manipal Hospice and Respite Centre (MHRC). This vital support will significantly enhance the quality of palliative and rehabilitative care provided to patients and families, reinforcing MAHE's commitment to compassionate healthcare. Siemens Healthineers supports Manipal Hospice Therapy Block The Manipal Hospice and Respite Care was inaugurated in May 2025 by the Honble Justice Shri S Abdul Nazeer, His Excellency the Governor of Andhra Pradesh, and was operational from June 2025. The Therapy Block at MHRC is a 6,100-square-foot facility, which has been meticulously designed to provide comprehensive rehabilitative and supportive care, featuring dedicated spaces for physiotherapy, occupational therapy, mind-body therapy, speech and swallow therapy, home-based occupational therapy, and counseling. The Therapy Block aims to enhance the comfort, independence, and dignity of patients, addressing their physical, cognitive, and emotional needs. Speaking on the collaboration, Hariharan Subramanian, Managing Director of Siemens Healthcare Pvt Limited said, 'The Therapy Block at the Manipal Hospice and Respite Centre, a pioneering hospice care initiative in India, addresses critical unmet needs of terminally ill patients. Our collaboration with MAHE to establish this therapy block reflects our shared commitment to fostering positive health outcomes and enhancing societal well-being within the communities we serve.' Driving Impact Through Collaboration This contribution is part of Siemens Healthineers' broader vision to pioneer breakthroughs in healthcare for everyone, everywhere. The company's partnership with Manipal Academy of Higher Education (MAHE) exemplifies the impact of industry-academia collaboration in transforming care delivery and supporting healthcare providers across the patient care continuum-from prevention and early detection to diagnosis, treatment, and aftercare. Applauding collaboration with Siemens Healthineers' on this high-impact social initiative Lt Gen (Dr) MD Venkatesh, VSM (Retd) Vice Chancellor of MAHE, stated, 'MHRC is a pathbreaking initiative that advances our mission to deliver specialized, empathetic, and academically rooted healthcare. The support from Siemens Healthineers and other partners has been instrumental in realizing this vision.' Manipal Hospice and Respite Centre, a 100-bed facility spread over 12 acres, is the first hospice in India to be affiliated with both a hospital and a university. It is the second largest hospice in India and aims to serve both patients with cancer and non-cancer. This hospice offers respite care as well as end-of-life care for both adults and children. About Siemens Healthineers Siemens Healthineers pioneers' breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at Siemens Healthineers in India has a countrywide sales network and round-the-clock service set-up, two manufacturing facilities at Vadodara for Diagnostics and at Bengaluru for Medical Imaging Products, backed by a state-of-the-art R&D center as well as a global software development center at Bengaluru. With over 7,000 employees across the nation, Siemens Healthineers is playing a significant role in transforming care delivery in India and supporting healthcare providers across the entire range of patient care-from prevention and early detection to diagnosis, treatment, and aftercare. Further information is available at About Manipal Academy of Higher Education The Manipal Academy of Higher Education (MAHE) is an Institution of Eminence Deemed-to-be University. MAHE offers over 400 specializations across the Health Sciences (HS), Management, Law, Humanities & Social Sciences (MLHS), and Technology & Science (T&S) streams through its constituent units at campuses in Manipal, Mangalore, Bengaluru, Jamshedpur, and Dubai. With a remarkable track record in academics, state-of-the-art infrastructure, and significant contributions to research, MAHE has earned recognition and acclaim both nationally and internationally. In October 2020, the Ministry of Education, Government of India, awarded MAHE the prestigious Institution of Eminence status. Currently ranked 4th in the National Institutional Ranking Framework (NIRF), MAHE is the preferred choice for students seeking a transformative learning experience and an enriching campus life, as well as for national & multi-national corporates looking for top talent.
